PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
20-May-2022 SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference SAE Media Group
19-May-2022 mdgroup Growth sees New VP, Product Delivery, Investing for the Future mdgroup
19-May-2022 IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program IAVI and Moderna, Inc.
19-May-2022 Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London Medidata
18-May-2022 Successful Completion of Phase I Study for Lead Asset EP395 EpiEndo Pharmaceuticals
17-May-2022 N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform N4 Pharma
17-May-2022 PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022 PureTech
17-May-2022 4D pharma presents late breaking abstract from Phase I/II trial of MRx-4DP0004 for the treatment of asthma at the American Thoracic Society (ATS) 2022 International Conference 4D pharma
17-May-2022 PT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine, significantly reduced the risk of a severe exacerbation compared to albuterol by 27% in patients with asthma AstraZeneca
17-May-2022 Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca’s PT027 in asthma patients in the New England Journal of Medicine Avillion
17-May-2022 Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy Sanofi
12-May-2022 This move is important to you. To support you to get that job, PharmiWeb.Jobs are delighted to announce they’ve partnered with CareerJay CareerJay, PharmiWeb
12-May-2022 Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials Novotech Health Holdings Pte Ltd
11-May-2022 Vagarights to Investigate the Use of Natural Stimulants to Treat ADHD VAGARIGHTS
11-May-2022 Evaluate appoints Matthew Wright as Chief Financial Officer RealWire
10-May-2022 Paradigm4 launches REVEAL: Proteomics to transform protein bio-marker research Paradigm4
10-May-2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis UCB
09-May-2022 Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey mdgroup
06-May-2022 Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction AstraZeneca
05-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences